Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 46 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Kotoula, Vassiliki  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Papaioannou, M., Sapalidis K., & Kotoula V. (2008).  Alleviation of myelodysplastic syndrome-associated skin rush after treatment with decitabine.. Eur J Haematol. 81(6), 489-90.
Pentheroudakis, G., Kotoula V., Koliou G-A., Karavasilis V., Samantas E., Aravantinos G., et al. (2018).  AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.. Clin Colorectal Cancer. 17(4), e631-e637.
Pentheroudakis, G., Mavroeidis L., Papadopoulou K., Koliou G-A., Bamia C., Chatzopoulos K., et al. (2019).  Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.. Clin Colorectal Cancer. 18(4), e370-e384.
Mitsiades, C. S., McMillin D., Kotoula V., Poulaki V., McMullan C., Negri J., et al. (2006).  Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.. J Clin Endocrinol Metab. 91(10), 4013-21.
Rallis, G., Koletsa T., Saridaki Z., Manousou K., Koliou G-A., Kostopoulos I., et al. (2019).  Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.. Anticancer Res. 39(4), 2129-2138.
B
Mitsiades, C. S., Hayden P., Kotoula V., McMillin D. W., McMullan C., Negri J., et al. (2007).  Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.. J Clin Endocrinol Metab. 92(12), 4845-52.
Romanidou, O., Kotoula V., & Fountzilas G. (2018).  Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas.. Cancer Genomics Proteomics. 15(5), 421-436.
C
Tsakiri, K., Kotoula V., Lakis S., üller J., Fostira F., Bobos M., et al. (2017).  Crizotinib Failure in a TPM4-ALK –Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation. JCO Precision Oncology. 1 - 7.
Mountzios, G., Kotoula V., Kolliou G-A., Papadopoulou K., Lazaridis G., Christodoulou C., et al. (2019).  Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab.. ESMO Open. 4(2), e000441.
D
Televantou, D., Karkavelas G., Hytiroglou P., Lampaki S., Iliadis G., Selviaridis P., et al. (2013).  DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.. Pathol Oncol Res. 19(2), 329-43.
E
Mitsiades, C. S., Kotoula V., Poulaki V., Sozopoulos E., Negri J., Charalambous E., et al. (2006).  Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.. J Clin Endocrinol Metab. 91(9), 3662-6.
Cohen, S. A., Wu C., Yu M., Gourgioti G., Wirtz R., Raptou G., et al. (2016).  Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.. Clin Colorectal Cancer. 15(2), 164-9.
Christodoulou, C., Oikonomopoulos G., Koliou G. Angeliki, Kostopoulos I., Kotoula V., Bobos M., et al. (2018).  Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.. Cancer Genomics Proteomics. 15(6), 461-471.
Fountzilas, G., Dafni U., Bobos M., Kotoula V., Batistatou A., Xanthakis I., et al. (2013).  Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.. BMC Cancer. 13, 163.
Koutras, A., Lazaridis G., Koliou G-A., Kouvatseas G., Christodoulou C., Pectasides D., et al. (2018).  Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.. PLoS One. 13(12), e0207707.
Korantzis, I., Kalogeras K. T., Papaxoinis G., Kotoula V., Koutras A., Soupos N., et al. (2012).  Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.. Anticancer Res. 32(10), 4569-80.
G
Zarkavelis, G., Kotoula V., Kolliou G-A., Papadopoulou K., Tikas I., Karavasilis V., et al. (2019).  Genetic mapping of pancreatic cancer by targeted next-generation sequencing e. ESMO Open. 4(5), e000525.
Chatzopoulos, K., Kotoula V., Koliou G-A., Giannoulatou E., Papadopoulou K., Karavasilis V., et al. (2020).  Genotype - phenotype associations in colorectal adenocarcinomas and their matched metastases.. Hum Pathol.
Linardou, H., Kotoula V., Kouvatseas G., Mountzios G., Karavasilis V., Samantas E., et al. (2019).  Genotyping and Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.. Cancer Genomics Proteomics. 16(6), 531-541.
I
Razis, E., Kalogeras K. T., Kotoula V., Eleftheraki A. G., Nikitas N., Kronenwett R., et al. (2012).  Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.. Clin Breast Cancer. 12(3), 183-93.
Kotoula, V., Bobos M., Kostopoulos I., Kaloutsi V., Koletsa T., Karayannopoulou G., et al. (2006).  In situ detection of hTERT variants in anaplastic large cell lymphoma.. Leuk Lymphoma. 47(8), 1639-50.
Kim, S., Fotiadu A., & Kotoula V. (2005).  Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia.. Clin Immunol. 115(3), 286-94.
Ooi, M. G., Hayden P. J., Kotoula V., McMillin D. W., Charalambous E., Daskalaki E., et al. (2009).  Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomib.. Clin Cancer Res. 15(23), 7153-60.
M
Polychronidou, G., Kotoula V., Manousou K., Kostopoulos I., Karayannopoulou G., Vrettou E., et al. (2018).  Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.. PLoS One. 13(12), e0208221.
Kotoula, V., Hytiroglou P., Kaloutsi V., Barbanis S., Kouidou S., & Papadimitriou C. S. (2002).  Mismatch repair gene expression in malignant lymphoproliferative disorders of B-cell origin.. Leuk Lymphoma. 43(2), 393-9.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές